Scientists Transplant Genetically Modified Pig Lung into Human for First Time: A Pioneering Step in Xenotransplantation

Spread the Message

Read Time:4 Minute, 31 Second

In a landmark medical experiment conducted at the First Affiliated Hospital of Guangzhou Medical University, scientists successfully transplanted a genetically modified pig lung into a human recipient for the first time. This unprecedented surgery marks a crucial advance in xenotransplantation—the transplantation of organs from animals to humans. The pig lung functioned for nine days in the recipient, who was declared brain-dead, providing a critical proof of concept that genetically engineered pig lungs could potentially augment or replace human lungs in future transplants. This experimental procedure was closely monitored and reported in the journal Nature Medicine in 2025.

Key Findings and Procedure Details

The lung donor was a Bama miniature pig, genetically engineered with six targeted edits using CRISPR technology to enhance compatibility with the human immune system. Specifically, three pig genes encoding immune-triggering sugars were knocked out to reduce rejection risks, while three human genes regulating inflammation and immune responses were inserted to help the lung evade immune attack. Importantly, the pig was raised in a sterile environment to further reduce infection risks.

In the patient, who had suffered a devastating brain hemorrhage and was declared brain-dead, surgeons replaced the left lung with the genetically modified pig lung while leaving the right lung intact to support breathing. Over a monitoring period of 216 hours (nine days), the transplanted lung successfully oxygenated blood and removed carbon dioxide, demonstrating functional capacity in a human thoracic environment.

However, the lung did encounter complications. Although it avoided immediate hyperacute rejection (a common early barrier in xenotransplantation), it developed significant tissue swelling due to fluid accumulation within 24 hours. By the third day, the organ sustained immune-mediated damage driven by antibody and complement system attacks. The experiment was terminated on day nine, highlighting both the promise and the extraordinary immunological challenges that remain.

Expert Perspectives and Context

Xenotransplantation specialists emphasize the complexity of lung transplants compared to other organs such as kidneys or hearts. Lungs perform multiple essential functions beyond gas exchange, including blood filtration, temperature regulation, platelet production, and defending against pathogens inhaled during breathing. These multifaceted roles make lungs exceptionally vulnerable to immune rejection and damage after transplantation.

Dr. Richard Pierson, a professor of surgery at Harvard Medical School and Massachusetts General Hospital who researches xenotransplantation, characterized the results as “a little optimistic” regarding full functionality but acknowledged the experiment as an important milestone. He underscored the necessity for further genetic modifications and improved immunosuppressive treatments to extend lung xenograft survival and reduce immune injury.

Current advances in related fields, including genetic engineering of pigs by companies such as Clonorgan Biotechnology in China and US-based eGenesis and Revivicor, are focused on producing pigs with organs that are less likely to trigger immune rejection and free from zoonotic viruses. Additional approaches under review involve transient immune suppression and neutralization of antibodies to prevent damage.

Public Health Implications and Challenges

The shortage of available human donor lungs is dire. Globally, only 8,236 lung transplants were performed in 2024, a number far below the growing demand. Thousands of patients die each year waiting for suitable donor lungs. Xenotransplantation offers a promising solution to bridge this gap by providing an abundant and potentially safer source of organs.

However, the path to clinical application is long and complicated. The immune response to pig lungs is formidable, and overcoming rejection has proven more difficult than in other xenotransplant procedures. According to the research team and external experts, additional modifications to the pig genome and optimized immunosuppressive protocols will be critical next steps. Moreover, ensuring the absence of zoonotic infections and long-term safety remains essential.

Potential Limitations and Counterarguments

While the nine-day function of the pig lung in a human recipient is groundbreaking, the experiment’s limitations deserve attention. The presence of the patient’s native right lung meant the pig lung’s sole life-supporting capacity could not be definitively proven. Also, the immune system eventually mounted a damaging attack, an obstacle that current gene edits and drugs could not completely prevent.

Skeptics caution against viewing this pioneering case as immediately translatable to clinical practice. There is a risk that premature enthusiasm could overshadow the need for comprehensive safety, efficacy, and ethical evaluations before widespread use. Moreover, concerns about long-term immune compatibility, pathogen transmission, and organ durability remain.

Practical Implications for Readers

For people facing lung transplantation or supporting loved ones on waiting lists, this research signals hope for future alternatives. It suggests that gene-edited pig lungs might someday expand the donor pool and save lives. However, it is equally important to recognize that this technology is experimental and will require years of additional research, clinical trials, and regulatory assessment before becoming a safe treatment option.

Meanwhile, public health strategies to increase human organ donation, improve immunosuppressive therapies, and advance transplant care continue to be vital. Patients and families should remain informed but cautious about emerging technologies like xenotransplantation and consult healthcare professionals about current treatment options.

Medical Disclaimer

This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.